Qdenga

Qdenga

tetravalent dengue vaccine (live, attenuated),Qdenga is indicated for the prevention of dengue fever in persons aged 4 years and older. Application to the upper arm in the deltoid area.

 

Vaccination scheme

Qdenga is to be administered in two doses of 0.5 ml (month 0 and month 3).

 

When is it necessary to postpone vaccination?

You must not be acutely ill at the time of vaccination, physical exertion, visiting the sauna, solarium, or large consumption of alcoholic beverages is not recommended on the day of application. The interval between the previous and next vaccination must be at least 2 weeks. You must not take antibiotics at the time of vaccination.

Most commonly reported side effects

Soreness, tenderness, redness and swelling at the injection site.

Pregnancy, breastfeeding

It is not recommended to vaccinate pregnant and breastfeeding women.

Notice

All information given here is for information purposes only. The choice of vaccine or vaccination schedule is always up to the doctor after a personal consultation at the vaccination centre.